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ABSTRACT
Carissimi, Alissa M. MS. The University of Memphis. May 2015. Interactions among
bacteria and Batrachochytrium dendrobatidis: An investigation of amphibian host
immune response. Major Professor: Dr. Matthew J. Parris.
The potentially fatal dermatophytic fungus, Batrachochytrium dendrobatidis (Bd),
is one of the most significant contributors to the extensive amphibian declines occurring
worldwide. However, some bacteria, such as Janthinobacterium lividum and
Pseudomonas fluorescens, found on amphibian epidermal tissues, water, and soil,
effectively inhibit Bd in vitro. To determine if these probiotics would promote Bd
resistance of the southern leopard frog (Lithobates sphenocephalus) in the presence of
microflora, frogs were inoculated with J. lividum and/or P.fluorescens. Once colonized
by probiotics, Bd-induced mortality did not occur when compared to frogs that were not
colonized by J. lividum and P. fluorescens. Those infected with Bd prior to bacterial
exposure were resistant to colonization and succumbed to chytridiomycosis. Future
research must address bioaugmentation strategies using techniques that identify disease
associated changes on the epidermis. J. lividum and P. fluorescens did not colonize Bdinfected L. sphenocephalus; therefore, are not suitable anti-Bd bacteria for this anuran
species.
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Chapter 1: Exposure of Lithobates sphenocephalus to probiotic bacteria for
colonization
Introduction
Conceptual Framework
Our understanding of symbioses between animals and microorganisms has developed
in recent years, focusing on the application of probiotics to animals for disease
mitigation. Amphibians rely partially on epidermal probiotics for defense and immunity
against pathogens, such as the chytrid fungus, Batrachochytrium dendrobatidis (Bd).
Their epidermal tissues act as a defense against pathogens, and immune function of this
barrier relies significantly on the bacterial community composition. The composition of
bacteria on amphibian epidermal tissues includes the probiotic species diversity and
relative abundances to one another. The combination of innate immune responses and
epidermal bacteria composition significantly influence amphibian disease susceptibility
(Bletz et al. 2013; Duda, Vanhoye, & Nicolas, 2002; Jani & Briggs, 2014; Loudon,
Woodhams et al. 2014; Rollins-Smith, 1998).
The most significant threat to amphibian populations worldwide is chytridiomycosis, a
disease caused by the pathogenic fungus, Bd (Crawford, Lips & Bermingham, 2010;
Walke & Vredenburg 2008). Infecting its hosts by motile zoospores in the water, Bd
colonizes and compromises the epidermal tissues of amphibians, causing mortality
through cardiac arrest via electrolyte depletion, excessive skin sloughing, and disruption
of cutaneous respiration (Voyles et al. 2007). In order to alleviate significant applications
of fungicides, and anti-fungal probiotics have been used to rid some amphibians of
chytridiomycosis (disease associated with Bd) in captivity (e.g., itraconazole; Forzan,
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Gunn, & Scott, 2008; Harris, Lauer, Simon, Banning, & Alford, 2008; Woodhams et al.
2014). Fungicides however, often cause negative side-effects that alter amphibian
immunity, growth, and development; therefore, many are not suitable treatments against
Bd (Brühl, Schmidt, Pieper, & Alscher, 2013; Igbedioh, 1991). The pesticide carbaryl
inhibits the release of antimicrobial peptides (AMPs), amphibians’ first line of defense
against disease, onto their skin (Davidson et al. 2007), which can lend them more
susceptible to Bd. Thus, the use of fungicides in aquatic communities to treat Bd, poses a
mortality risk to amphibians. Instead of applying detrimental chemicals to treat Bdinfected amphibians, non-lethal probiotic bacteria can be used for Bd inhibition (Harris et
al. 2009; Matz et al. 2012; Muletz, Myers, Domangue, Herrick, & Harris, 2012).
Furthermore, the presence of many amphibian pathogens is directly correlated with the
properties of probiotic species within their environment, and their relative abundances to
other microbes (Jani & Briggs, 2014). If anti-Bd probiotics can colonize an amphibian,
and are common (i.e., high abundance) in a Bd susceptible population, the likelihood of
Bd remaining in that population is decreased.
Amphibian probiotics isolated from the Red-backed Salamander, Plethodon cinereus,
among others, protect them from Bd infection (Harris et al. 2008). These bacteria,
Janthinobacterium lividum and Pseudomonas fluorescens, produce the metabolites
violacein and 2, 4-diacetylphloroglucinol (2, 4-DAPG) that successfully inhibited Bd
growth on culture plates (Brucker, Baylor et al., 2008; Brucker, Harris et al., 2008). The
minimum inhibitory concentration (MIC) of such probiotics is the concentration at which
they inhibit 50% of Bd growth. Inhibition of Bd to concentrations below 10,000 zoospore
equivalents (i.e., the mortality threshold for Bd) is associated with decreased mortality in
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amphibians (Vredenburg, Briggs, & Harris, 2011). The MIC for J. lividum and P.
fluorescens has been quantified (Brucker et al. 2008; Harris et al. 2009; Muletz et al.
2012; Myers, 2012) and therefore, can be used to inoculate hosts at the appropriate
concentrations for Bd mitigation. However, the MIC for these bacteria toward Bd has not
been examined in the presence of epidermal microflora on the Southern Leopard Frog,
Lithobates sphenocephalus. The MIC regarding Bd for newly introduced bacteria may be
altered in response to the presence of other amphibian epidermal microorganisms and Bd,
so it is necessary to determine the probiotic MICs for Bd in the presence of native
(naturally occurring) aquatic and epidermal microorganisms. Equally important, is to test
if probiotics need be reapplied if Bd susceptible hosts experience repeated exposure to
this pathogen.
Literature Review
Bd mitigation strategies should consider the differential immune response of
amphibians to exposure. The immune response of Bd-infected amphibians varies among
species, and one explanation may be the differing metabolites produced by established
microorganisms on their epidermis (Woodhams et al. 2007). Probiotic metabolites
(violacein, 2, 4-DAPG), directly reduce Bd concentrations in inhibitory assays
demonstrating that bioaugmentation strategies are feasible (Becker, Brucker, Schwantes,
Harris, & Minbiole, 2009; Harris et al. 2009). However, when topically applying J.
lividum and P. fluorescens, the immune response of L. sphenocephalus could be
stimulated in a manner that could prevent these bacteria from colonizing. The presence of
the pathogen Bd, however, may facilitate the colonization of introduced probiotic species
by altering the amphibians’ epidermal community composition (Bletz et al. 2013). For
3

example, J. lividum has been shown to increase violacein production on P. cinereus
epidermal tissues in the presence of Bd (Becker et al. 2009) thereby, conferring resistance
to Bd and increased survivorship compared to unexposed controls. In contrast, other
bacteria that are negatively correlated with Bd have been shown to decrease as a result of
infection; thereby, creating a conundrum (Jani & Briggs, 2014). In order to address this
issue, current research must consider both the host and pathogen dynamics for accurate
epidemiological measurements.
The mechanisms by which amphibian AMPs and epidermal microflora combat Bd are
not completely understood. In many amphibian species, the secretion of AMPs from the
granular glands is stimulated by both abiotic (e.g., temperature, UV radiation) and biotic
(e.g., pathogens, predators) stressors (Duda et al. 2002; Rollins-Smith & Conlon, 2005).
The composition of AMP secretions (i.e. peptide families) is species specific and once
released onto the epidermal tissues, the AMPs can disrupt the hydrophobic portions of a
pathogens’ cell membrane, thus killing it (Tennessen et al. 2009). Several families of
AMPs, such as brevinin-1 and ranatuerin-2, inhibit the growth of Bd thus allowing Bd
infected hosts to maintain zoospore loads below mortality thresholds (Rollins-Smith &
Conlon, 2005). Similarly, Probiotic bacteria, P. fluorescens and J. lividum, successfully
inhibit Bd colonization on epidermal tissues once inoculated onto amphibian epidermal
tissues (e.g., Red-Legged Frog, Rana muscosa) (Harris et al. 2009). Rana muscosa does
not harbor either species of probiotic bacteria in vivo, but both successfully colonized this
host; demonstrating the potential for other Bd susceptible species to acquire new
microbial symbionts. J. lividum and P. fluorescens can also act synergistically with
endogenously produced AMPs to increase the efficacy of Bd inhibition in laboratory
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settings (Myers et al. 2012). Currently, these have not been confirmed on amphibian
epidermal tissues in the presence of resident microflora. The presence of L.
sphenocephalus microflora may alter J. lividum and P. fluorescens colonization.
Competition, niche availability, and resources are also factors on amphibian tissues that
may prevent colonization by newly introduced probiotics (Bletz et al. 2013; Woodhams
et al. 2012). Furthermore, the palpable and molecular changes resulting from Bd infection
will certainly influence microbiome stability.
Bio-augmentation with P. fluorescens and J. lividum as a strategy to mitigate Bd
impacts must be considered cautiously. The addition of non-native microbes could create
non-target effects in which other species are negatively impacted. However, Scherwinski
et al. 2008 found that adding P. fluorescens to control the agricultural disease,
Rhizoctonia solani, was an effective treatment for lettuce with no adverse effects on nontarget species. Moriarty (1998) found an increase of prawn survival at an Indonesian farm
after introducing Bacillus harveyi; this bacterial species decreased the proportion of
pathogenic luminous Vibrio spp. in the water and sediment. Similarly, bio-augmentation
of a North American amphibian species, such as the L. sphenocephalus, with J. lividum
and P. fluorescens should pose little risk to non-target organisms given both probiotics
are native to North America and commonly found in rivers and soil (Pantanella et al.
2006). Combining both probiotics could serve as a better strategy to control
chytridiomycosis in vivo because each has a different mechanism of Bd inhibition (Duran
et al. 2007; Gleeson, O’Gara, & Morrissey, 2010).
Exposing L. sphenocephalus to J. lividum and P. fluorescens in the presence of
microflora will establish the most ecologically relevant bio-augmentation strategy;
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previous research has done so by first removing resident microbes via antibiotics and/or
hydrogen peroxide (Becker et al. 2011; Harris et al. 2008). Pre-treatment such as this can
cause dysbiosis, in which amphibian microbiota is altered so as to lend them more
susceptible to illness and disease (Jani & Briggs, 2014; Woodhams et al. 2014).
Vredenburg et al. (2011), topically applied the probiotic J. lividum to Rana muscosa
during an epizootic Bd wave without first removing epidermal microbes, and found
survivorship of those treated was more than twice that of controls (77% vs. 30%).
However, no studies have treated susceptible hosts with multiple bacterial species
concurrently both before and after infection by Bd. In doing so, conservation efforts and
bd mitigation strategies can be applied to natural populations, if successful.
L. sphenocephalus is susceptible to Bd infection at all life stages, and infections in
adults can result in death (Peterson, Wood, Hopkins, Unrine, & Mendonça, 2007;
Rothermel et al. 2008).The efficacy of probiotics on L. sphenocephalus epidermal tissues
can be quantitatively measured by the individuals’ response to Bd exposure. L.
sphenocephalus produces brevinin-1 AMPs in response to pathogens (Conlon et al.
2009). Currently, there is no evidence that J. lividum or P. fluorescens exist on L.
sphenocephalus epidermal tissues, even though they are sympatric. Bio-augmentation of
soil with J. lividum and P. fluorescens provides protection against Bd for other
amphibians, even though these bacteria have not been found on their epidermis (Muletz
et al. 2012), and by inoculating L. sphenocephalus with J. lividum and P. fluorescens in
the presence of resident epidermal microbes, I will test the hypotheses that colonization
of L. sphenocephalus by these probiotic bacteria is contingent upon microflora and AMP
production.
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Hypotheses
J. lividum and P. fluorescens will not colonize L. sphenocephalus epidermal tissues
because of inhibition by the combination of AMPs and preexisting microorganisms. The
innate immune responses, such as AMPs, will prevent the ready uptake of J. lividum and
P. fluorescens onto L. sphenocephalus epidermal tissues. L. sphenocephalus individuals
collected at Shelby farms, TN tested negative for the presence of these bacterial species;
therefore are less likely to acquire new bacterial community members. Furthermore,
given L. sphenocephalus share habitats with J. lividum and P. fluorescens found in soil
and water, this species would have most likely acquired these bacteria if advantageous to
either party and so, it is reasonable to assume the host and bacteria are incompatible.
Alternatively, the presence of endogenous AMPs and epidermal microflora may not
impact colonization by newly introduced bacteria. These experiments are designed to
distinguish between these hypotheses.
Methodology
Animal Husbandry
Four L. sphenocephalus egg masses were collected in March 2013 from three ponds
and reared in mesocosms at the Meeman Biological Field Station (N35° 21 ', W90°'),
Shelby County, Tennessee. Mesocosms simulate a natural pond and ensure individuals
are naïve to Bd (Rowe & Dunson, 1994). Once individuals underwent metamorphosis
(approximately 9-13 weeks), they were transported to the laboratory in containers washed
with 10% bleach. Raising L. sphenocephalus metamorphs in the lab ensures that
individuals are at the same developmental stage and experience the same environmental
conditions. Each metamorph was housed individually in 1 L laboratory containers, fed
7

Reptivite©-dusted crickets ad libitum, and water changes were made as needed.
Individuals were housed thusly for approximately 20 weeks, at which point frogs were
exposed, and capable of producing the full range of adult AMPs (Rollins-Smith, 1998).
Probiotic Cultures
Probiotic suspensions of J. lividum and P. fluorescens were grown in 1% tryptone
broth. Prior to exposing individual frogs to their respective treatments, it was necessary to
determine the exponential growth phase for each bacterial species. During the
exponential growth phase, bacteria are reproducing at a constant rate, thereby
maximizing the chances of successful colonization (Huang, 2013; Monod, 1949). To
determine exponential growth for each probiotic, I constructed a standard growth curve
using optical density (OD) measurements at one hour intervals for 12 hours after a 24
hour incubation period using a spectrophotometer with wavelength at 590 nm (Sheafor,
Davidson, Parr, & Rollins-Smith, 2008). By interpolating each sample to the standard
growth curve, I confirmed the concentrations of each probiotic and their exponential
growth phase based upon their OD reading. I determined that the concentrations were
highest approximately 28 hr after inoculation of 1% tryptone broth media. In addition, I
confirmed that after 48 hr, bacterial concentrations steadily declined. The concentrations
at 28 hr were much higher than was needed to inoculate each frog therefore; I made serial
dilutions and measured the OD of each to confirm which were necessary to achieve 1 x
106 cells/mL. Bacteria were supplied by Dr. Reid Harris at James Madison University,
Virginia.
Viable cell counts were conducted by transferring swabs onto tryptone plates with
antibiotics, rifampin and penicillin. Both J. lividum and P. fluorescens were plated on
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rifampin and penicillin gradients in which the concentration of each antibiotic gradually
increased, and resistant colonies from the highest concentration were transferred.
Rifampin and penicillin resistant colonies were transferred until the highest antibiotic
concentration in the tryptone plates was 1%; a level that exponentially exceeds that found
in nature. This ensures isolation of J. lividum and P. fluorescens from L. sphenocephalus
epidermal tissues; therefore, these two bacteria can be differentiated from each other
based upon morphology. Colony forming units (CFUs, hereafter) of J. lividum are
characteristically dark purple due to violacein production. P. fluorescens is
morphologically similar to many species of bacteria; therefore, culturing and selecting for
antibiotic resistance of this species was necessary to differentiate it from resident L.
sphenocephalus microbes.
AMP Collection, Purification, and Efficacy
I isolated AMPs from L. sphenocephalus on November 18th, 2013 (one day prior to
treatment exposure) by injecting individuals with 10 nM norepinephrine (NE, hereafter)
(0.1 mL/g body weight) and placing frogs in a collection buffer (50mM sodium chloride,
25mM sodium acetate, pH 7.0) for 15 min. Once collected, 1% Trifluoroacetic acid was
added to each AMP suspension to prevent proteolytic degradation (Rollins Smith et al.
2006) and stored at -4°C. Once thawed, each sample was then filtered through C-18 SepPaks (Waters Corporation). Isolated AMPs were then serially diluted and the
concentrations from each serial dilution were determined by measuring OD readings and
comparing those to the peptide standard, Bradykinin (Micro BCA protein assay kit,
Thermo Scientific®). Bovine serum albumin included in the microBCA protein assay kit
was not used because amphibian AMPs are more similar in molecular size to the
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bradykinin peptide. OD readings from L. sphenocephalus AMPs are determined by the
pigment intensity from the dye; this increases with peptide concentration. OD readings
quantified frog AMPs ranging in concentrations from 80 µg/mL to 250 µg/mL. The MIC
of L. sphenocephalus AMPs against each probiotic was performed via growth inhibition
assay; each well in a 96 well micro plate contained a different concentration of AMPs
from the serial dilutions of 250, 100, 50, 25, 10, and 5µg/mL. Each dilution was
subsequently inoculated under a sterile laminar flow hood with 1 x 106 cells/mL of J.
lividum and P. fluorescens independently, and in combination the concentration of each
probiotic was 1x103 cells/mL. By measuring the optical density of each well at Day 0 and
Day 7, I quantified the MIC for each concentration of AMPs against the probiotics. The
MIC for AMPs is defined as the concentration by which they inhibit 50 percent of the
growth of microorganisms, such as probiotics and Bd zoospores. These MIC values are
analogous to standard LC50 values Eco-toxicologists use to assess the lethal
concentration of a given toxin (i.e., pollutant, insecticide, pesticide etc.) that will cause 50
% mortality in a wild population (Traunspurger et al. 1997). The MIC of endogenous L.
sphenocephalus AMPs against probiotics J. lividum and P. fluorescens were quantified.
The AMP MIC for J. lividum was 200 µg/mL, and for P. fluorescens, it was 150 µg/mL.
Therefore, if individuals produce AMP concentrations that exceed the levels mentioned
above, this will most likely prevent J. lividum and P. fluorescens from colonizing L.
sphenocephalus. Although bacteria rapidly reproduce when transferred to a host or new
substrate, if 50 percent of the original inoculum is inhibited by AMPs, it is less likely that
neither probiotic can reach sufficient numbers to colonize L. sphenocephalus.
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Probiotic Exposure and Quantification
After quantifying AMP MIC against each bacterial species, AMPs were collected
from resting adults by placing them in the collection buffer after a 2 nM NE injection. All
treatments were prepared in a new sterile container for each frog, and contained a 30mL
bacterial suspension with 1% NaCl and sterile tap water. More specifically, at 20 weeks,
eight individuals were inoculated with each of the following treatments during the
exponential growth phase for the bacteria: 1) J. lividum+/P. fluorescens+ (i.e., positive
control); 2) J. lividum+/ heat-killed P. fluorescens; 3) heat-killed J. lividum/P.
fluorescens+; and 4) heat killed J. lividum and P. fluorescens (i.e., negative control). The
incubation period for each bacterium was 48 hours to ensure transmission and/or
colonization of each frog. At 48 hours, a fresh pair of nitrile gloves was used for each
individual frog to transfer them into new containers with fresh water. Each frog was
swabbed on days 1, 2, 4, 9, 17, 24, 28, and 35 post inoculations. Swabs from each frog
were placed in 1mL of sterile water and this water was transferred aseptically to 1%
tryptone plates with 10% rifampin. Viable cell counts were performed 24 hours after each
frog was swabbed on days 1, 2, 4, 9, 17, 24, 28, and 35 by counting the number of CFUs
on plates that had incubated for 24 hours. The number of CFUs for each probiotic was
compared to that from the original inoculation concentration (1x 106 CFU/mL) by
converting the number of CFUs into the same unit of measurement for concentration (see
Equation).
Number of CFU

Number of CFU

Volume plated (mL) x total dilution used

mL
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(1)

Statistical Analyses
All statistical analyses were performed using SPSS 21 software. One-way Analysis Of
Variance (ANOVA) was used to test for differences between and within treatment groups
for each day sampled (N = 40). Tukey’s post-hoc analysis was used to determine which
treatment groups significantly differed. All days were then tested together for treatment
effects over time using repeated-measures MANOVA for both probiotic samples and
AMP production.
Results
The MIC for L. sphenocephalus AMPs to inhibit J. lividum was 200µg/mL and for P.
fluorescens was determined to be 150µg/mL. None of the AMPs collected from 2mM NE
injections (mild stressor) exceeded this MIC; each individual was inoculated based upon
their respective treatment group.
Comparisons of Bacterial Cell Concentrations Over Time
MANOVA showed there were no significant differences between treatments with J.
lividum and the positive control for the duration of the experiment (F1,12 =1.48, p =
0.403). The bacterial loads from colonization by J. lividum and the positive control did
not differ; there were no additive effects resulting from co-culture exposure in treatment
group 1 (see Figure 1). Viable cell counts demonstrated the colonization of L.
sphenocephalus by each bacterial species. Each swab from individuals in bacterial
treatment groups yielded a minimum of 100 CFUs. Repeated-measures MANOVA
compared the number of probiotic cells for each sample day. Bacterial loads on frogs
varied significantly among treatment groups on all sample days (F3,29 = 296.19, p < 0.01.
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Average # of cells (Millions)

L. sphenocephalus Probiotic Cell Counts
2.5
2
1.5
Positive Control
1
J. livium only
0.5
0
1
-0.5

2

4

9

17

24

28

35

P. fluorescens
only
Negative
Control

Time (Days)

Figure 1. Probiotic cell counts on L. sphenocephalus epidermal tissues over 35 day period. Treatment x
Time was significant at α < 0.05.

Multiple comparisons revealed that L. sphenocephalus in treatment groups containing
J. lividum or P. fluorescens differed significantly from the negative control (see Figure
1). The concentrations from day 24 onward were similar and time effects were not found
when comparing concentrations of each treatment group on day 24 (p = 0.403), 28 (p =
0.374), and 35 (p = 0.984). The fixed concentrations from day 24 onward were most
likely the result of probiotic establishment (i.e., symbiosis) with L. sphenocephalus.
Concentrations on individuals in each of the treatment groups did not decrease below
those on day 9; therefore, probiotics colonized because they remained at levels similar to
the inoculum concentration at day 0. Tukey’s post-hoc analyses showed a significant
difference in the number of bacterial cells between those individuals inoculated with
either J. lividum or P. fluorescens. Individuals inoculated with J. lividum had higher cell
concentrations on average, than those inoculated with P. fluorescens (F1,12.= 6.873, p =
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0.01). These results suggest that P. fluorescens colonized L. sphenocephalus at lower cell
densities than those of J. lividum; abundance differences are observed among many taxa.
AMP production in response to bioaugmentation
Repeated-measures MANOVA confirmed that significant differences in AMP
production between treatment groups occurred over time (F1,28 = 11.604, p = 0.04) (see
Figure 2). Introducing J. lividum and P. fluorescens to a naïve amphibian species
mounted a differential immune response, yet AMP production did not inhibit growth or
kill these bacteria.

L. sphenocephalus AMP Production
AMPs micrograms/mL

140
120

*

100

*
*

80

* *
Positive Control

60

J. lividum only

40

P. fluorescens only
Negative Control

20
0
0

7

35

Time (Days)

Figure 2. Changes in L. sphenocephalus AMP concentrations over 35 day period. Time effects were
significant at F = 11.604, P = 0.04. Significant differences are indicated with an asterisk (*).

Differential AMP production was not observed for individuals in co-culture groups;
these frogs did not produce more AMPs than those inoculated with only one bacterial
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species. There were no significant differences in L. sphenocephalus AMP production
between any of the treatment groups prior to inoculation with anti-Bd bacteria (F3,28 =
0.716, p = 0.557). Multiple comparisons showed no significant differences for L.
sphenocephalus AMP production between any bacterial treatment groups on Days 7, and
35 (p = .352), this was most likely the result of probiotic establishment. In contrast, the
negative control and co-culture groups differed significantly (see Figure 2); roughly 10%
AMP production for negative control as compared to co-culture frogs (p < 0.01).
Mauchly’s test of sphericity was used for within-subjects tests, and no significant
differences for AMP production were observed, suggesting that innate immune responses
were consistent among individuals (p > 0.05). Variations in AMP production have been
observed among members of the same species; however, in vitro conditions may have
eliminated such variation.
Discussion
Findings and Conclusions
The results from this study suggest that L. sphenocephalus was successfully colonized
by J. lividum and P. fluorescens; therefore, these probiotics may be effective for
preventative and/or treatment regimens against Bd. However, the colonization by both
bacteria may not be necessary, as there were no additive effects (i.e., increased bacterial
loads) on L. sphenocephalus epidermal tissues when combining the two. This in part,
could be the result of niche availability and niche construction by both bacteria on L.
sphenocephalus epidermal tissues.
Niche construction is the modification of a particular niche by metabolic processes,
physical activities and preferences of the introduced organism; for bacteria such as J.
15

lividum and P. fluorescens, this would most likely include fixing nutrients (Odling-Smee,
Laland, & Feldman, 2003). Fixing nutrients is an important metabolic process common
among bacterial symbionts because the host benefits from bacterial colonization by more
efficiently obtaining nutrients than otherwise (Postgate, 1998). For example, Rhizobium
soil bacteria fix nitrogenous compounds found on the roots of many plants and without
these bacteria breaking down these compounds, the plants could not utilize nitrogen in
the soil (Sprent, 1987). Amphibian/bacterial symbiosis depends upon several factors,
such as nutrient composition, osmolarity, and interactions with previously established
resident microbes (Belden & Harris, 2007). Competitive inhibition of microbes occurs
quite frequently (Laland & O’Brien, 2010), therefore; it could be that in
combination, J. lividum and P. fluorescens are competing for L. sphenocephalus skin
resources, thereby preventing additive effects of colonization.
J. lividum may be a better candidate for Bd mitigation strategies, as it colonizes in
significantly higher concentrations than P. fluorescens, which may in turn, reduce the
spatial availability for Bd zoospores more effectively. The mechanisms by which these
probiotics colonized L. sphenocephalus are not well understood and further studies
should address the probiotic nutrient uptake, possible changes in both the microbial
community composition and niche construction on L. sphenocephalus epidermal
tissues to better understand this complex symbiosis.
The AMP production of L. sphenocephalus was shown to increase over time in all
treatment groups; this could be due to the growth of the individuals during
the experiment. AMP production of an individual is a function of its mass (Rollins-Smith,
2002), and all individuals were less than 2g when inoculated with probiotics and most
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exceeded this weight by day 35. Conversely, treatment effects were shown to be
statistically significant. All but the negative treatment group exhibited increased AMP
production until day 7, and then decreased through day 35. One possible explanation is
that during the colonization process, immune response was heightened until symbiosis
among host and probiotics was established. An overactive immune response to J. lividum
and P. fluorescens may explain the decrease in AMPs over time as a result of an energy
trade-off; once AMPs are depleted, it may take up to 60 days to replenish those (RollinsSmith & Woodhams, 2011). An investigation into the decrease in AMP production
should be performed to assess other possible immunological explanations.
P. fluorescens colonized L. sphenocephalus, but cell concentrations were not as high
as J. lividum. It could be possible that P. fluorescens can successfully inhibit Bd zoospore
growth and development to the same extent as J. lividum, but at much lower cell
concentrations. P. fluorescens may serve as a keystone probiotic species, whereby
significant contributions to L. sphenocephalus immunity can occur in the presence of Bd
and so, both probiotics should be tested for the prevention and/or treatment of
chytridiomycosis. For example, Bletz et al. (2013) found that keystone probiotic species
had large effects on amphibian microbial community composition even though cell
concentrations were low relative to already established species. P. fluorescens could
produce larger quantities of anti-Bd metabolites than that of other bacterial species. If P.
fluorescens produces larger quantities than J. lividum, the amount of Bd inhibition by
each bacterium may be similar when J. lividum is at significantly higher cell
concentrations. The relative abundances of newly introduced probiotics directly effects
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an amphibians’ immune response to pathogens, such as Bd, and this is the most likely
explanation for the differences observed among and within amphibian populations.
Recommendations for Future Research
Both J. lividum and P. fluorescens can be topically applied, and if colonization occurs,
as it did with L. sphenocephalus, probiotics should then be tested in preventative and
treatment regimens against Bd. More recent findings (Jani & Briggs, 2014) support
proposed probiotic colonization as Bd alters the microbial communities of infected
amphibians, and this change can promote bacterial colonization. More importantly
however, is the need to understand the extent to which bacteria can colonize individual
amphibians across Bd host populations. Future studies can test if probiotics will colonize
amphibian hosts despite Bd-induced changes in microbial community structure if added
to a natural system in vivo. Before such experimentation can occur, it is necessary to
expose Bd susceptible hosts to the disease after anti-Bd bacterial colonization has been
confirmed in the presence of resident epidermal microbiota.
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Chapter 2: Susceptibility to Bd after Successful Colonization of
L. sphenocephalus with J. lividum and
P. fluorescens
Introduction
Conceptual Framework
Amphibians host a broad range of microorganisms on their epidermis, and most
provide fitness advantages via symbioses. Bacteria utilize amphibian resources once
colonized onto their epidermal tissues, and in turn, contribute to the amphibians’
immunity against pathogens (Jani & Briggs, 2014; Woodhams et al. 2014). Bacteria
alone however, may not be enough to prevent, treat, or cure an individual of an
exceptionally virulent pathogen. The pathogen Batrachochytrium dendrobatidis (Bd) is
an infectious fungus, responsible for global amphibian declines over the last two decades.
Bd alters the composition of amphibian epidermal tissues, characteristically hardening
(hyperkeratosis) and sloughing off the stratum cornetum and dermis (Berger, Hyatt,
Speare, & Longcore, 2005). Bd exploits the physical constraints of amphibians (i.e. moist
skin for cutaneous respiration) by transmitting infection via motile zoospores in water
and moist soil (Johnson & Speare, 2003). This is significant to conservationists who want
to implement Bd mitigation strategies because amphibians will travel and potentially
transport zoospores into new watersheds to hydrate their skin.
Once a Bd zoospore reaches a suitable amphibian host, it will attach to the stratum
corneum, and develop into a thallus (fruiting body). The thallus then matures into a
zoosporangium and expels several new zoospores to either re-infect the current host, or
find a new one. At this point the lifecycle for Bd is complete and will occur over a 5-7
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day period (Berger et al. 2005). Bd symptoms can remain undetected in some amphibian
species (Xenopus laevis) are asymptomatic, and can serve as Bd carriers, transmitting
infection in susceptible species with which they share habitats (the disease associated
with Bd) (Rollins-Smith et al. 2005; Voyles et al. 2007). Infected amphibians can
succumb to chytridiomycosis (disease associated with Bd) within days to months,
demonstrating the high inter/intra species variability of symptom severity and mortality.
Literature Review
It is necessary to assess the potential candidates for the prevention of Bd transmission
and infection because no clear patterns have been observed, thus preventing accurate
predictions. However, there is a positive correlation between the survival of Bd infected
amphibians and the probiotic species present on their epidermal tissues (Harris et al.
2009; Jani & Briggs, 2014; Vredenburg et al. 2011; Woodhams et al. 2014). Many
probiotics reside on these tissues because of the permeability and abundant nutrients
available to them, similarly, making the amphibian epidermis ideal for infection by
pathogens (Bletz et al. 2013; Woodhams et al. 2014). This was demonstrated when
amphibians colonized by the probiotic, Janthinobacterium lividum, had better
survivorship when exposed to Bd (Harris et al. 2009). J. lividum produces the metabolite
violacein which disrupts metabolic function and the structural integrity of Bd cells
throughout the Bd lifecycle (Durán et al. 2007). Furthermore, J. lividum produces a
biofilm allowing cells to outcompete and kill other microorganisms, such as Bd, without
harming the host (Pantanella et al. 2007). The probiotic species Pseudomonas fluorescens
also inhibits Bd in vitro by producing the metabolite 2, 4- diacetylphloroglucinol (2, 4DAPG) (Brucker et al. 2008). P. fluorescens is commonly used in agriculture as a
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successful, low-risk biological control to prevent black rot in U.S. corn crops (Showkat,
Murtaza, Laila, & Ali, 2012). Therefore, J. lividum and P. fluorescens should be
considered as preventatives for Bd infection in amphibians.
Amphibians have a plethora of microbial species on their epidermal tissues that serve
beneficial functions, including, an acquired immune response that contributes to pathogen
resistance (Bletz et al. 2013; Jani & Briggs, 2014; Woodhams et al. 2014). This collective
group of microorganisms living on amphibian tissues makes up the epidermal community
composition of that individual. The epidermal community composition of an individual
amphibian is highly variable; depending upon brooding behavior, exposure history, and
whether a symbiosis can occur. Variance of epidermal community composition can occur
within and between amphibian species (McKenzie, Bowers, Fierer, Knight, & Lauber,
2011). For example, isolated populations of the same frog species had different bacterial
symbionts depending upon their Bd exposure history (Jani & Briggs, 2014). Some
amphibian populations are continuously exposed to Bd, often during an epizootic wave
resulting in massive losses. Such instances make most Bd disease parameters (i.e.
transmission, susceptibility, infection, and resistance) difficult to predict across and
within wild populations. Patterns of Bd susceptibility, infectivity, and resistance are not
definitive for most amphibian populations because there are vast differences among both
host species and Bd strains (Berger, Marantelli, Skerratt, & Speare, 2005; Gahl,
Longcore, & Houlahan, 2012). However, many probiotics can be used to prevent and
treat Bd infection in amphibians, if they can colonize, and maintain virulence toward Bd.
For example, Vredenburg et al. (2011) confirmed that probiotic treatment can be effective
if Bd infection is low (below 10,000 zoospore equivalents) at the time of treatment.
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Bd is an immunosuppressant of susceptible amphibians, and often causes death if
infection progresses to 10,000 zoospore equivalents (mortality threshold in susceptible
hosts) (Vrendenburg et al. 2011). Symptoms of chytridiomycosis include the restriction
of cutaneous gas exchange, skin sloughing, electrolyte, and osmotic imbalance (Brutyn et
al. 2012; Voyles et al. 2007). In larval amphibians, despite having a gelatinous body,
their keratinized mouthparts become infected with Bd resulting in decreased foraging
efficiency and developmental stress (Fellers, Reed & Longcore, 2001; Parris &
Cornelius, 2004; Venesky, Wassersug, & Parris, 2010). Furthermore, Bd zoospores
secrete compounds that disrupt cell-to-cell communication in amphibian skin by altering,
if not, destroying intercellular junctions (Brutyn et al. 2012). When Bd attaches to
amphibian epidermal tissues, it initiates the sympathetic nervous system, accompanying
norepinephrine (NE) production to stimulate muscle contractions (Rollins-Smith &
Conlon, 2005). These muscle contractions increase respiration, heart rate, and oxygen
consumption; this signals for antimicrobial peptides (AMPs) to be released from the
granular glands in amphibians. AMPs are released onto amphibian epidermal tissues to
defend them against invading pathogens (Pask, Cary, & Rollins-Smith, 2013). AMPs
produced by amphibians are intraspecific and the arsenal of peptide families varies
widely among individuals (Roelants et al. 2013; Tennessen et al. 2009). Many species of
ranid frogs have two families of peptides, brevinin-1 and ranatuerin-2; both prevent Bd
zoospore growth and development when isolated and purified (Rollins-Smith & Conlon,
2005). The mechanisms by which leopard frog AMPs promote disease resistance are well
understood (Myers et al. 2012; Pask, Woodhams & Rollins-Smith, 2012; Tennessen et al.
2009). As such, the production of the peptide family brevinin-1 is common by the
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Southern Leopard Frog, Lithobates sphenocephalus; and so, this species is the model
organism for this study. Amphibian AMP production however does not always result in
microorganism death, if it could serve as a symbiont (i.e., probiotic bacteria).
The innate and acquired immune responses of amphibians exhibit a cross-talk that
improves response efficacy when threatened by a pathogen, and allow for colonization by
probiotics (Bletz et al. 2013; Küng et al. 2014; Richmond, Savage, Zamudio, &
Rosenblum, 2009; Woodhams et al. 2007). This cross-talk can occur between Bdinhibitory probiotics (acquired from the environment or topically applied) and
endogenously produced immunomodulators, such as AMPs. The combination of AMPs
and probiotics is likely the most successful candidate for the prevention of
chytridiomycosis in amphibians without using chemically derived anti-fungals. For
example, when topically applied to Plethodon cinereus, J. lividum concentrations
increased as a result of Bd exposure (Bletz et al. 2013), suggesting that both the host and
symbionts can detect pathogenic threats. Biological controls, such as probiotic bacteria,
provide an effective mitigation strategy against fungal diseases of many plants and
animals, and can be applied to amphibian systems as well (Jousset, Rochat, Scheu,
Bonkowski, & Keel, 2010; Showkat et al. 2012).
Secondary metabolites produced by the bacterial species, J. lividum and P.fluorescens,
effectively inhibit Bd growth and reproduction at relatively low concentrations (Becker &
Harris, 2010; Bletz et al. 2013; Brucker et al. 2008; Harris et al. 2009; Lauer, Simon,
Banning, Lam, & Harris, 2008; Muletz et al. 2012). When Lithobates sphenocephalus
was exposed to both, J. lividum and P. fluorescens (Chapter One), AMP production
increased, but not enough to inhibit bacterial proliferation; therefore, the probiotics
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successfully colonized this species. Microorganisms within the epidermal community
composition of L. sphenocephalus also allowed for colonization by J.lividum and
P.fluorescens. Viable cell counts conducted at several time intervals over a 35 day period
revealed that bacterial concentrations remained high enough to inhibit Bd. These results
suggest that L. sphenocephalus is an ideal candidate to test if newly colonized probiotics
in conjunction with host AMPs will prevent Bd-induced mortality in this species. To
further assess the efficacy of J. lividum and P. fluorescens for Bd inhibition, colonized L.
sphenocephalus will be subsequently exposed to Bd.
Hypotheses
J. lividum and P. fluorescens will reduce L. sphenocephalus susceptibility
to Bd infection as a result of successful probiotic colonization (Chapter 1). Co-occurring
bacterial treatments and endogenously produced AMPs will inhibit Bd growth and host
mortality more effectively than individual probiotic treatments. This additive effect for
Bd inhibition was demonstrated when both probiotic metabolites (violacein and 2,4DAPG), and endogenously produced AMPs were isolated and purified in vitro (Myers et
al. 2012). Furthermore, AMP production of L. sphenocephalus will increase as a result of
Bd exposure, more so than individuals not previously colonized by J. lividum and P.
fluorescens. This experiment will test these hypotheses by experimentally infecting L.
sphenocephalus previously colonized by J. lividum and P. fluorescens with Bd.
Methodology
Exposure of L. sphenocephalus to Bd
Eight L. sphenocephalus metamorphs (25 weeks old) were used in five treatments for
an array of 40 experimental units. All individuals in this experiment were treated and
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handled in accordance with the approved IACUC protocol #0735. Each metamorph was
housed separately, fed twice per week with crickets dusted in Reptivite© vitamins and
water was changed as needed. Individuals in treatments 1, 2 and 3 were individuals
colonized by probiotics as described in Chapter 1. Bd isolate FMB 003 was transferred to
1% tryptone plates and cultured for 7 days to inoculate L. sphenocephalus. Several
different sub-cultures of this isolate were plated to determine which had the most viable
zoospores in each aliquot. Zoospores were stained using malachite green and placed in a
hemacytometer. Upon counting zoospores, it was evident that sub-culturing had lensed
the pathogen attenuated (Brem, Parris, & Padgett-Flohr, 2013; Langhammer et al. 2013).
In a typical 10 µL sample, one would observe hundreds of zoospores; my samples
contained, on average, fewer than two dozen. As a result, I reintroduced Bd to five L.
sphenocephalus frogs that were not included in the experiment for two weeks. Bd will
become virulent after reintroduction onto a new host if it has been sub-cultured for
extensive periods of time (Brem et al. 2013). FMB003 did not become more virulent;
zoospore concentrations did not increase when re-isolated from L. sphenocephalus.
Instead, I obtained a fresh frozen stock culture of FMB 003 from Dr. Rollins-Smith at
Vanderbilt University in Nashville, TN. This new culture grew exponentially when
introduced into 1% tryptone broth, and in 7 days, zoospore counts were increased
significantly as compared to the isolate that had been repeatedly sub-cultured. The
concentration of zoospores/mL was then calculated at 4 x 108 zoospores/mL based upon
the number of zoospores from the 10 µL sample within each quadrant of hemacytometer.
Zoospores were then harvested by rinsing Bd culture plates with sterile HPLC grade
water, and subsequently filtering the rinse into a 10mL syringe. The filtrate was then
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passed through a 10 µm filter to isolate Bd zoospores and to remove thalli/zoosporangia.
The optical density was measured in order to determine the concentration of the zoospore
suspension. The amount of light that passes through the sample is its optical density (OD,
hereafter). The values from the microplate reader are converted into concentrations by
comparing them to a standard curve of known concentrations. To construct a standard
curve, Bd suspensions were serially diluted (full strength, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6,
10-7) and placed in 24 wells (triplicate for each dilution) of a 96-well microplate. OD
readings at 590nm of the zoospore solution were used to ensure each frog in the Bd
treatment group was inoculated with the same Bd concentration (1 x 106 zoospores/mL).
The Bd serial dilution of 10-2 was 1 x 106 zoospores/mL; therefore, this dilution of FMB
003 was used for L. sphenocephalus individuals in Bd treatment groups. Individuals in all
treatments, except treatment 4, were inoculated with Bd zoospores. Treatments were as
follows: 1) co-culture with J. lividum and P. fluorescens; 2) J. lividum; 3) P. fluorescens
+; 4) Negative control with heat killed J. lividum, P. fluorescens, and Bd; 5) Positive
control with Bd only. A fresh pair of nitrile gloves was used to transfer each individual
into a 1L container (washed with 10% bleach) with ionized water (1% NaCl).
10mL Bd suspensions (1 x 106 zoospores/mL) were transferred, using a pipette,
directly into the ionized water containing L. sphenocephalus in treatment groups 1, 2, 3,
and 5 for 7 days (one Bd life cycle) to ensure transmission. After 5 days, a fresh pair of
nitrile gloves was used for each individual to remove them from their respective
treatments, and placed back into new, clean 1L containers with water.
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Probiotic and Bd quantification
Every L. sphenocephalus in the experiment was swabbed for Bd on sample days 2, 4,
9, 17, 24, 35 and 43, until it was no longer detected, or an individual died. Viable cell
counts were performed on all sample days, and concentrations for both J. lividum and
P.fluorescens were confirmed until Day 43, at which point all individuals in the positive
control group had died. Cell counts were obtained from the probiotics that had been
transferred to antibiotic plates from the swabs. Colonies of J. lividum and P. fluorescens
were quantified after a 24 hour incubation period (Miles, Misra, & Irwin, 1938). Swabs
were then frozen at -4ºC. Once thawed, any DNA present on the swabs was then
extracted and purified using Qiagen DNeasy blood and tissue extraction kit©, so that Bd
could be quantified using qPCR. The purified DNA from each swab was then combined
with SYBR Green Master Mix and Bd oligonucleotides that were optimum for SYBR
Green chemistry. I performed this procedure using methods from previously published
research, in accordance with Sigma Aldrich© protocol (Kirshtein, Anderson, Wood,
Longcore, & Voytek, 2007; Nolan, Hands, & Bustin, 2006). Six out of eight L.
sphenocephalus individuals in the Bd-positive control group had died before Day 35,
consequently; Bd and AMP concentrations for only 2 individuals could be determined for
the full duration of the experiment. Individuals that died before day 35 were sampled
until death, and those that survived were humanely euthanized using MS-222 at the
conclusion of the experiment.
AMP Collection, Purification, and Quantification
Each individual in the experiment was rinsed with 50mL of sterile water to remove
any transient microbes. To test for changes in AMP concentrations as a result of probiotic
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colonization and Bd exposure, each individual was injected with the appropriate volume
of 2µg/mL of norepinephrine (NE) on days 7 and 35. After NE-injection, each L.
sphenocephalus was placed in a collection buffer for 15 min to collect their crude
peptides. Using 1% Trifluoroacetic acid, each crude peptide mixture was preserved and
frozen; this step is necessary to prevent oxidative damage by DNAses, proteases and
other enzymes.
After several months, Crude peptide mixtures were thawed to room temperature and
after activating sep-paks with buffers A and B, each sample was filtered using column
chromatography (Sep-Pak® C18). Each conical containing the purified AMPs were spun
down in a centrifuge designed for 50mL falcon tubes, and after 8 hours, was completely
dried. In order to quantify the concentrations of each AMP sample, an assay was
performed, according to the manufacturer (Micro BCA protein assay kit, Thermo
Scientific®). A bradykinin protein standard was serially diluted to concentrations of 400,
200, 50, 25, 10, 5, 2.5, and 1 µg/mL because these are typical concentrations of AMPs
collected from L. sphenocephalus. The bradykinin peptide was used in place of the
bovine serum albumin included in the assay kit because it is structurally similar to AMPs
produced by amphibians. AMP samples were then placed into the wells at full strength
and half dilution (replicates of three), and averaged using Gen X 5 software. Each 96well plate was read twice at a wavelength of 570nm to ensure accuracy and minimize any
error. Replicate averages with more than 10% variation were excluded and not used for
later analyses. All AMP purification and analyses were performed at Vanderbilt
University in Nashville, TN.
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Quantitative Polymerase Chain reaction (qPCR) Analysis
Frozen Bd swabs were analyzed using qPCR and the previously established protocol
for SYBR Green Chemistry and Bd primers (Longcore et al. 2007; Harris et al. 2009). In
order to make such quantifications, Bd serial dilutions of 1x107, 1x106, 1x105, 1x104,
1x103, 1x102, 1x101, and 1x10-1 were used as standards, and were compared to swab
samples in the qPCR microplate. The more DNA present, the more binding to SYBR
green fluorescent dye, confirming the concentrations of Bd zoospores relative to the
standard concentrations. Each sample in the qPCR microplate was run in triplicate and
those that deviated more than ten percent, were not used for later analysis. After
approximately 20 cycles, DNA from the samples was amplified to confirm concentrations
of Bd zoospores per swab; samples containing minute amounts of Bd took as many as 40
cycles for DNA amplification.
Statistical Analyses
Treatment and time effects for L. sphenocephalus AMP production were tested with
repeated-measures ANOVA using 2 sample days and 5 treatment levels (N = 34).
Repeated-measures MANOVA was used to determine treatment effects over time for
both viable cell counts of probiotics and qPCR zoospore quantification (N = 36). Changes
in probiotic cell concentrations and Bd zoospore loads contained 8 sample days, 2
exposures and 5 treatment levels. One individual from treatments 2 and 3 died, and two
individuals in the positive Bd control group died as a result of Bd exposure by day 5. All
individuals that died were preserved in 10% formalin. Harmonic means were used for
individuals in Bd positive control because only 2 individuals survived beyond one week.
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Results
Bd-induced Changes of AMP Production
Using MANOVA, time effects for each treatment group were confirmed, and there
were significant differences for L. sphenocephalus AMP production on day 7 (F =
14.141, p < 0.01) and day 35 (F = 14.452, p = 0.019). As seen in figure 3 (next page),
AMP production in each of the treatment groups, except for the negative control, differed
significantly over time as a result of exposure to Bd (F2, 3 = 32.121, p < 0.01).
There were no significant differences in AMP production between individuals with
both probiotics/Bd and those in the P. fluorescens/Bd (F = 14.925, p = 0.219) or the
J.lividum/Bd groups (F = 14.925, p = 0.912). Therefore, AMP production in response to
Bd exposure was similar regardless of what bacterial species had colonized L.
sphenocephalus or if J.lividum and P. fluorescens were combined. There were also
significant treatment effects over time the concentrations of AMPs within treatment
groups increased in response to Bd. Significant differences for L. sphenocephalus AMP
production were observed on day 7 between groups as a result of treatment exposure
(F4,36 = 7.775, p < 0.01) and between individuals (F8, 36 = 31 p < 0.01).
Bacterial Concentrations Fluctuates Post-Bd Infection
Probiotic cell counts were significantly different among treatment groups for all
sample days (F6,20 = 9.390, p = .002; see Figure 4, next page). Probiotic cell
concentrations on L. sphenocephalus epidermal tissues differed depending upon the
bacterial species and/or combination of species that previously colonized this host. Time
effects occurred for all treatment groups (treatment x time); probiotic concentrations
significantly differed between sample days (F2 = 5.608, p = 0.013).
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Figure 3. L. sphenocephalus AMP concentrations over 35 day period. Treatment x Time was significant at
α = 0.05.
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Figure 4. L. sphenocephalus probiotic concentrations over a 43 day period. Treatment x Time was
significant on all sample days P < 0.05.
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In response to Bd exposure, probiotic cell concentrations changed over time
independent of their presence with one another. There were no significant differences
between individuals within probiotic treatment groups containing both probiotics (F1,7 =
2.626, p = 0.123) J. lividum (F1,7 = 1.758, p = 0.201), or P. fluorescens (F1,8 = 2.283, p =
0.131). The negative control group and the positive control group were excluded from
probiotic analyses because they tested negative for both probiotics when swabs were
plated on days 2 and 4.
Probiotic Inhibition of Bd zoospores
The qPCR results revealed significant differences for Bd zoospore loads between
treatment groups over time (see Figure 5; F1,4 = 14.494, p < 0.01). The most significant
decrease in Bd zoospores on L. sphenocephalus was for individuals that had been
previously colonized by J. lividum (on average reduced by 20 percent by Day 43).
Individuals in the positive control maintained Bd zoospore concentrations of 1x106
zoospores/swab or higher; there were no significant differences between individuals
within the positive control group (F1,2= 3.014, p = 0.095). Significant differences
between individuals previously colonized with J. lividum and P. fluorescens (p < 0.01)
were confirmed by Tukey’s post-hoc analysis. L. sphenocephalus treated with J. lividum
had significantly less Bd zoospores than those treated with P. fluorescens (p = 0.022).
There were no significant differences in Bd zoospore loads between those in the J.lividum
and those in the positive control (p = 0.772). All individuals within the negative control
group tested negative for the presence of Bd zoospores.

32

L. sphenocephalus Bd zoospore
concentrations

9000000
Zoospore concentrations

8000000
7000000

Bd + / J. lividum + /
P. fluorescens +
Bd + / J. lividum + /
P. fluorescens Bd + / J. lividum - / P.
fluorescens +
Positive Control Bd
only

6000000
5000000
4000000
3000000
2000000
1000000
0
2

4

9

17

24

35

43

Days after Bd exposure
Figure 5. L. sphenocephalus zoospore concentrations after colonization by probiotics. All treatment groups
were significantly less than the positive control.

Discussion
Discussion of Findings and Conclusions
The results of this study suggest that the use of probiotics for a Bd prevention regime
can be promising. Both J. lividum and P. fluorescens lessened the Bd mortality rate of L.
sphenocephalus when compared to the treatment group that was not previously colonized
by them. Therefore, L. sphenocephalus individuals who have a symbiotic relationship
with J.lividum and/or P. fluorescens are less susceptible to chytridiomycosis. This is also
true for wild amphibians that host these bacteria within their epidermal microbial
community (Brucker et al. 2008; Culp, Falkinham III, & Belden, 2007; Küng et al. 2014;
Lauer, Simon, Banning, Lam, & Harris, 2008). Research findings for amphibianbacterial symbioses suggest that J. lividum and P. fluorescens extend the host’s immune
system by allowing them to acquire some level of resistance to Bd (Bletz et al. 2013). For
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colonization by J. lividum and P.fluorescens to occur, these bacteria may have
competitively inhibited one or more previously established microbes on L.
sphenocephalus epidermal tissues (Jani & Briggs, 2014; Woodhams et al. 2014). Frogs in
this experiment were reared in the laboratory, which may have contributed to the ready
uptake of the probiotics after a short duration. It may be that wild L. sphenocephalus have
a broader, and more complex epidermal community composition containing microbes
that could alter colonization by J.lividum or P. fluorescens (McKenzie et al. 2011).
L. sphenocephalus AMP concentrations did not influence probiotic concentrations,
despite the Bd-induced increase of AMPs over time. If AMP concentrations exceed the
MIC to inhibit J. lividum and P. fluorescens, the number of bacterial cells for each would
have declined significantly or decreased to zero. It may be that the energy requirement
for L. sphenocephalus AMPs to effectively inhibit probiotics was not necessary for Bd
inhibition in the presence of epidermal microbes (Garner et al. 2009). Amphibians with
relatively low AMP production have substantial amounts of other immune defenses, such
as bacterial symbionts, and behavioral adaptations (Harris et al. 2009; Walke, Harris,
Reinert, Rollins‐Smith, & Woodhams, 2011). Moreover, L. sphenocephalus AMP
production could be solely the result of Bd exposure because J. lividum and P.
fluorescens had colonized this host several weeks prior.
The combination of L. sphenocephalus AMPs and probiotics, J. lividum and P.
fluorescens, (treatment group 1) was no more potent against Bd than either one of the
probiotics (treatment groups 2 and 3). The additive effect in Myers et al. (2012) was
observed for purified bacterial metabolites and amphibian AMPs eluted from crude
peptides, so other compounds produced by bacterial cells and the crude peptides on L.
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sphenocephalus could have diminished the efficacy of violacein and 2,4-DAPG. The
crude peptides of amphibians are comprised of several peptide families, not including
AMPs. L. sphenocephalus crude peptides could have regulated the bacterial
concentrations of probiotics in combination, thereby, preventing them from exceeding
some threshold value (Conlon et al. 2009; Pask et al. 2012; Rollins-Smith & Conlon,
2005). It is now understood that the mucosal microbiome of amphibians is often times
dictated by the interactions between innate immune responses (AMPs, lymphocytes, and
enzymes), and acquired immune responses (exposure history, colonization by microbes,
behavior) that may upregulate them (Richmond et al. 2009; Kung et al. 2014; Woodhams
et al. 2014).
Another explanation for this experiment as to why there were no additive effects
observed when combining J. lividum and P. fluorescens may be the spatial and nutritional
constraints imposed upon these bacteria from Bd-induced changes on L. sphenocephalus
epidermal tissues. The densities of J. lividum and P. fluorescens may have reached
carrying capacity due to limited resources, or competition between the two (Collinge &
Ray, 2006). Carrying capacity (defined as K), in this context, is the maximum number of
bacterial cells that can be sustained by resources on L. sphenocephalus epidermal tissues.
Such resources can include, niche availability, moisture, and nutrient
composition/availability on the epidermal tissues themselves (Jani & Briggs, 2014; Küng
et al. 2014; Laland & O’Brien, 2010). If the carrying capacity for the probiotics J.
lividum and P. fluorescens has been reached, populations of each naturally decline,
potentially rendering them less effective L. sphenocephalus immunomodulators for Bd
infection. Individuals in all treatment groups were experimentally infected with Bd, as
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such; changes of L. sphenocephalus epidermal tissues may have restricted bacterial
proliferation and additive effects in treatment group 1. Bd-infected individuals become
depleted of many nutrients, and this would limit the amount available to epidermal
microbes (Voyles et al. 2007). The nutrient and spatial availability after Bd infection
would be similar in all individuals exposed to Bd, and this would explain why bacterial
densities on L. sphenocephalus in treatment group 1 were not higher or more effective
than those in groups 2 and 3. Many of the patterns that arise from amphibian symbionts
interacting with their immunity can be used to assess future Bd mitigation strategies
(Woodhams et al. 2014). However, implementation of biological controls (J. lividum and
P. fluorescens) into an amphibian habitat must be done so with caution, and non-target
effects must be considered (sympatric organisms may acquire illness from exposure).
The threat of non-target effects can be minimal if J. lividum and P. fluorescens are to
be used in their native geographic locations (i.e. South Eastern United States and
Europe). For example, Woodhams et al. (2014) demonstrated the benefit of probiotics
Flavobacterium johnsoniae and P. fluorescens for treating Bd-infected Alytes
obstetricans (European common midwife toad). Both probiotics pose little risk to other
organisms because they are resident on several species of amphibians throughout Europe.
Minimizing non-target effects can be achieved if the chosen probiotics have amphibian
specificity whereby, other semi-aquatic organisms, such as reptiles and birds, cannot
become infected or colonized.
Recommendations for future research
The most suitable Bd inhibitors will be those bacteria that reside on amphibian species
that have a complex epidermal community composition (Bletz et al. 2013; Woodhams et
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al. 2014). Many amphibian probiotics serve as immunomodulators; however, they must
effectively inhibit Bd in the presence of microflora. This research suggests that J. lividum
and P. fluorescens maintain Bd inhibition on L. sphenocephalus tissues in the presence of
resident microbes and AMPs to a similar extent as previous research (Myers et al. 2012).
In order to consider in vivo bioaugmentation of L. sphenocephalus, subsequent studies
should address the presence of other organisms within the environment. Anti-Bd bacteria
must serve a similar function in other organisms they may be able to colonize. It is
possible that when an amphibian benefits from a particular bacterial species, a fish could
become a new host and that microbe serves as a pathogen, rather than probiotic (Collinge
& Ray, 2006). This is often demonstrated in animals with no exposure history to a given
microorganism; when they have not yet acquired immunity through crosstalk between the
innate and acquired systems.
To facilitate probiotic establishment, whole community level profiling of bacterial
populations should be performed on Bd susceptible amphibians to ensure that potential
Bd inhibitory bacteria are compatible with host microflora. Several studies have
introduced probiotic bacteria in the presence and absence of Bd after the removal of
resident microbes (Becker & Harris, 2011; Harris et al. 2009; Vredenburg et al. 2011).
“However, this pre-treatment is not always necessary and could remove microbes that
facilitate probiotic establishment or contribute to the defense against Bd” (Bletz et al.
2013). As such, it is critical to avoid alterations of the microbial community structure that
has been established on amphibian epidermal tissues because it may impair immunity.
This study indicates that amphibian microflora need not be removed in order to improve
immune function. Furthermore, by not removing previously established microbes, this

37

study is the most ecologically relevant approach for inoculating anti-Bd bacteria onto
amphibian epidermal tissues.
This research can be applied to future studies in which mesocosms can be used to test
if L. sphenocephalus can be colonized by J. lividum and P. fluorescens while considering
other variables. The presence of other animals, more microorganisms, and different
nutrients will influence the outcome when exposing L. sphenocephalus to J. lividum and
P. fluorescens. Furthermore, performing this experiment in a mesocosm could address
other aspects of amphibian immunity to Bd that would not be possible otherwise.
Daphnia magna (zooplankton) can consume Bd zoospores, and is present in waters that
L. sphenocephalus reside (Hamilton, Richardson, & Anholt, 2012). When present, D.
magna could alter L. sphenocephalus immune responses to Bd. Exposure amphibians to
organisms found within their natural habitat can be replicated in mesocosm studies, and
can provide ecologically relevant information. It is now known that many amphibian
microbes cannot be cultured in the lab, but while raising individuals in a mesocosm, we
can begin to unravel the complex interactions among host, its symbionts, and Bd. Data
obtained from this research study can now be used to test if J. lividum and P. fluorescens
are equally effective treatments for Bd infection as they are preventatives. In this follow
up study, L. sphenocephalus would be inoculated with J. lividum and P. fluorescens after
experimental infection by Bd is confirmed.
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Chapter 3: Addition of J. lividum and P. fluorescens to
BD-Infected L. sphenocephalus
Introduction
Conceptual Framework
Symbioses are common within a broad range of taxa, and benefit both host organisms
and good bacteria (i.e., probiotics). Probiotics can provide advantages to hosts that
promote longevity, specifically, by facilitating immune responses (Bletz et al. 2013; Jani
& Briggs, 2014). Conservation management plans often utilize probiotics to treat minor
infections, diseases, or improve physiological processes, such as digestion in species that
are experiencing significant population declines (Hajishengallis, Darveau, & Curtis,
2012; Madsen et al. 2001). “Keystone” probiotics are those that deliver benefits to their
host at low concentrations compared to other host microflora. The probiotic keystone
hypothesis states that the probiotic need only be added to the organisms’ microbial
community in low abundance for symbiosis to occur. The probiotic will significantly
impact the hosts’ microbial community structure and provide some benefit
(Hajishengallis, Darveau, & Curtis, 2012). Culturing such probiotics can prevent large
losses, if applied to wildlife systems facing an epizootic wave (Bletz et al. 2013). For
amphibians, such a bacterium would provide defenses against pathogens by remodeling
their epidermal community composition (Jani & Briggs, 2014; Woodhams et al. 2014).
Many amphibian species are susceptible to the fungal disease chytridiomycosis,
caused by the highly virulent pathogen, Batrachochytrium dendrobatidis (Bd). Bd is a
dermatophytic fungus (requiring keratin for growth) that infects the epidermal tissues (i.e.
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stratum cornetum, dermis) of its amphibian hosts (Richmond, Savage, Zamudio, &
Rosenblum, 2009). Water serves as the primary vector for Bd transmission whereby free
swimming Bd zoospores detect potential hosts via chemotaxis (Rosenblum, Stajich,
Maddox, & Eisen, 2008). Once attached to the epidermal tissues of an amphibian host,
Bd zoospores will mature into zoosporangia. When Bd zoosporangia have matured within
the epidermis, a discharge papilla forms from which newly formed zoospores are
expelled into the water to find keratin (Berger et al. 2005). The threshold for Bd-induced
mortality is reached once zoospore loads have exceeded 10,000 zoospore equivalents
(Vredenburg et al. 2011). Up until this point, susceptible individuals will experience a
multitude of disease symptoms associated with chytridiomycosis, such as sloughing off
of skin, electrolyte imbalance, and a marked decrease of cutaneous respiration (Voyles et
al. 2007). The risk for mortality in Bd susceptible amphibians often increases with
disease progression because symptoms worsen, and together can cause individuals to
undergo cardiac arrest. The epidermal community composition of Bd- infected
amphibians is also altered with chytridiomycosis progression (Bletz et al. 2013; Jani &
Briggs, 2014; Woodhams et al. 2014). Bioaugmentation of amphibian epidermal tissues
to prevent/treat infection by Bd has been successful using anti-dermatophyte
bacteria (Harris et al. 2008; Muletz et al. 2012; Vredenburg et al. 2011; Woodhams et al.
2014).
Amphibians have a microbial assembly on their epidermis and many members
produce secondary metabolites and biofilms which inhibit the growth and potential
transmission of Bd (Bell, 2012; Brucker et al. 2008a; Brucker et al. 2009; Loudon et al.
2014). Individual bacterial cells will uptake beneficial genes (virulence factors) as needed
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from other neighboring cells. Genes can be readily expelled if unnecessary, to conserve
energy. Probiotic virulence factors that protect amphibians from pathogens often depend
on the host’s exposure history to that particular pathogen. A positive correlation between
the concentration of violacein (a toxic metabolite to Bd) produced by Janthinobacterium
lividum and exposure of amphibian epidermal tissues to Bd is an example of such a case
(Bletz et al. 2013; Muletz et al. 2012). Vertical transmission of such probiotics occurs
frequently in amphibians that brood their eggs. While brooding, many Hyla spp. and
glass frogs transfer bacteria to the outer layer of their gelatinous eggs. As a result, the
eggs are less susceptible to fungal, parasitic, and bacterial infections (Walke, Harris,
Reinert, Rollins‐Smith, & Woodhams, 2011). Horizontal transmission of probiotics to
conspecifics can occur however, most amphibian species host distinct core microbes
obtained from the water and soil within their environment (McKenzie et al. 2011; Walke
et al. 2014).
Literature review
Anti-Bd probiotics, J. lividum and Pseudomonas fluorescens, have successfully
colonized amphibian hosts in vitro via bioaugmentation (Harris, Lauer, Simon, Banning,
& Alford, 2008; Jani & Briggs, 2014; Lauer & Hernandez, 2015; Loudon et al. 2014).
Each probiotic produces secondary metabolites that inhibit the growth and development
of Bd zoospores, resulting in drastic decreases in Bd zoospore concentrations on
amphibian epidermal tissues. The metabolite violacein produced by J. lividum acts on a
cellular level to lyse Bd zoospores (Pantanella et al. 2007), and 2, 4Diacetylphloroglucinol (2, 4-DAPG) produced by P. fluorescens, effectively slows the
development and progression of the Bd lifecycle (Harris et al. 2009; Lauer, Simon,
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Banning, Lam, & Harris, 2008; Muletz et al. 2012). Thus, these bacteria have become a
focal point for chytridiomycosis mitigation research. Moreover, J. lividum and P.
fluorescens stimulate the innate immune response of many Bd susceptible amphibians in
such a way that additive effects can occur when co-cultured. The combination of purified
secondary metabolites from co-cultures, and endogenously produced amphibian
antimicrobial peptides (AMPs), inhibited Bd more effectively (Myers et al. 2012).
However, other peptides are secreted from the granular glands in amphibians and so; this
study was not an accurate measure of this innate immune response. Amphibian AMPs
contribute equally to immune function during Bd exposure and must also be considered
before bioaugmentation of Bd-infected amphibians.
AMP production is the first innate immune response of amphibians, triggered by
abiotic and biotic stressors that can facilitate death or disease (Rollins-Smith, 1998). Such
abiotic factors include drastic temperature fluctuations, low humidity, and exposure to
chemicals. Biotic factors that influence amphibian AMP production include predators,
pathogens, and competition. AMP production by amphibians is a “flight or fight”
response instigated by the central nervous system. As a result, the adrenal medulla in the
amphibian brain stimulates muscle contractions via norepinephrine (NE) production.
Contractions of the smooth muscle surrounding amphibian granular glands, stimulates the
release of AMPs from an expulsion duct onto the epidermis (Rollins-Smith & Conlon,
2005). Once released, AMPs serve to lyse, degrade, and potentially kill pathogens on the
surface of amphibian epidermal tissues, thereby preventing infection, or in some cases,
death (Pask et al. 2013; Rollins-Smith & Conlon, 2005, Rollins-Smith, 2009). Due to the
immunities AMPs provide an amphibian, colonization of their epidermal tissues by J.
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lividum and P. fluorescens, may not be feasible. When selecting anti-dermatophytic
bacteria, AMPs produced by the model amphibian species should be considered, and
therefore, should not inhibit bacterial growth and colonization.
Bioaugmentation of amphibian epidermal tissues using J. lividum and P. fluorescens
has been a successful Bd mitigation strategy for some species (Harris et al. 2009; Becker
& Harris, 2011; Loudon, Holland et al. 2014; Vredenburg et al. 2011). This was
demonstrated in my current research, of which these probiotics successfully colonized the
Southern Leopard Frog, Lithobates sphenocephalus in vitro. This is significant because L.
sphenocephalus is susceptible to Bd and prior to this experiment, this species had not
been colonized by J. lividum and P. fluorescens prior to the removal of previously
established microbes (See Chapter 1). Pretreatment is not always necessary and could
remove microflora that facilitate probiotic establishment or contribute to the defense
against Bd (Bletz et al. 2013). Following Bd exposure, most L. sphenocephalus in J.
lividum and P. fluorescens treatment groups did not develop infection. Frogs in these
treatments that established Bd infection, maintained zoospore loads below the mortality
threshold of 10,000 zoospore equivalents (See Chapter 2). This evidence poses a
hypothesis, that it is possible that J. lividum and P. fluorescens could prevent Bd
transmission. If so, the likelihood of new Bd cases would decrease because symptoms
during the early stages of Bd infection can go undetected. J. lividum and P. fluorescens
target and destroy Bd zoospores on L. sphenocephalus when applied prior to Bd exposure
and as such; should be tested as a treatment for chytridiomycosis.
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Hypotheses
J. lividum and P. fluorescens will successfully colonize L. sphenocephalus after
infection by Bd. In response to Bd infection, L. sphenocephalus AMP production will be
impaired (Küng et al. 2014; Pask et al. 2012; Woodhams et al. 2014), thus allowing for
colonization by J. lividum and P. fluorescens. The presence of Bd infection will alter
microbial community composition in such a way that newly introduced antidermatophyte bacteria, will colonize L. sphenocephalus better in co-cultures than
separately (Jani & Briggs, 2014; Küng et al. 2014; Lam, Walke, Vredenburg, & Harris,
2010; Woodhams et al. 2014). Equally effective for the treatment and prevention of
chytridiomycosis, each bacterium will lessen Bd zoospore loads, and prevent mortality
after L. sphenocephalus is experimentally infected.
Methodology
Bacterial Exposure of Bd-Infected L. sphenocephalus:
Eight individuals in 5 different treatments were housed separately in 1L containers, for
a total of 40 ranid frogs. All individuals in this experiment were handled in accordance
with the approved IACUC protocol #0735. Frogs were fed live crickets (Acheta
domestica) twice per week, and sterile tap water (1% NaCl) was changed every 4-7 days.
Bd isolate FMB003 was transferred to 1% tryptone plates and cultured for 7 days to
inoculate L. sphenocephalus. On day 7, sterile HPLC grade water was used to rinse Bd
plates, and the suspension was pushed through a 10mL syringe with a 10 µm filter for
zoospore isolation. A separate Bd suspension with known concentration
(106zoospores/mL) was serially diluted (full strength, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7)
to obtain optical density (OD) readings using a spectrophotometer set at 590nm. These
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OD values were calculated for each dilution to create a standard curve. The same dilution
series for the known sample was used for the FMB003 suspension. The FMB003
suspension was placed into a 96-well microplate to determine which dilution was
106zoospores/mL. This was necessary to confirm that each frog in Bd exposure groups
was inoculated with the same concentration of zoospores.
By comparing OD values to the standard curve, I confirmed that the FMB003 dilution
of 10-2 was 1 x 106zoospores/mL. A fresh pair of nitrile gloves was used for each
individual to transfer them into a 1L container (washed with 10% bleach) with sterile
ionized water (1% NaCl). Using a pipette, 10mL Bd suspensions (1 x 106zoospores/mL)
were placed directly into the ionized water containing L. sphenocephalus in treatment
groups 1-4. After 5 days (one Bd life cycle), each individual was transferred to their
respective treatments into new, clean 1L containers using fresh nitrile gloves.
Once confirmed, Bd-positive frogs were then exposed to the following treatments
(30mL total volume, 1 x 106bacterial cells/mL) for 48 hours: 1) heat-killed J. lividum and
P. fluorescens; 2) J. lividum+/P. fluorescens+; 3) J. lividum+/P. fluorescens-; 4) J.
lividum-/P. fluorescens +. Bd negative frogs were placed in treatment 5) negative control
with heat-killed Bd followed by an application of heat-killed J. lividum and P.
fluorescens. Frogs were placed into new, washed containers with the corresponding
treatment for 48 hours to promote bacterial colonization. After 48 hours, all frogs were
transferred to separate, clean 1L containers using a fresh pair of nitrile gloves for each
individual. All but one individual in the Bd positive control group died within one week,
and so, there was no data for this group. All individuals that died during the experiment
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were preserved in 10% formalin. Individuals in the negative control group and those that
survived treatment exposure were humanely euthanized after day 35 using MS-222.
Bd and probiotic quantification
Each L. sphenocephalus was swabbed on their foot, hand webbing, and ventral surface
10 times using a sterile cotton swab on days 1, 4, 7, 12, 16, 19, 24, and 35. Swabs were
thawed on day 35 for DNA extraction and purification (Qiagen DNeasy blood and tissue
extraction kit©), in accordance with the manufacturers protocol. Purified DNA from the
swabs was frozen at -4°C until day 35. To quantify Bd zoospore concentrations using
qPCR, each purified DNA sample was then combined with SYBR Green Master Mix®
and Bd oligonucleotides (5.8S ribosomal RNA gene) that were optimum for SYBR
Green© chemistry. The procedure was performed using methods from previously
published research, and in accordance with Sigma Aldrich© protocol (Kirshtein,
Anderson, Wood, Longcore, & Voytek, 2007; Nolan, Hands, & Bustin, 2006). If Bd was
no longer detected on a swab or an individual died, that frog would no longer be used in
the analysis.
Immediately after swabbing each frog, swabs were streaked onto plates containing
rifampicin and penicillin to obtain viable cell counts for J lividum and P. fluorescens.
Both bacterial species used in this experiment had been sub-cultured to maintain
antibiotic resistance (Chapter 1). Colony forming units (CFUs) of J. lividum and P.
fluorescens were counted, and after 24 hours of incubation (26°C), concentrations were
quantified (Miles, Misra & Irwin, 1938) for each sample day. Until day 24, viable cell
counts from swabs were performed on the same sample days as those for qPCR. On day
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24, all individuals in bacterial treatment groups tested negative for J. lividum and/or P.
fluorescens. These frogs were no longer sampled after testing negative for bacteria.
AMP collection, purification and quantification
On days 7 and 35, each frog was rinsed with sterile water and injected with the
appropriate volume of 2µg/mL NE to test for changes in AMP concentrations from
bacteria and Bd exposure. Each individual was then placed in a collection buffer for 15
minutes to collect crude peptides. Using 1% Trifluoroacetic acid (preservative), each
crude peptide mixture collected was frozen.
Crude peptide mixtures were purified to isolate AMPs at Vanderbilt University in
Nashville, TN. First, the crude peptide mixtures were thawed and after activating SepPak® C18 with methanol, the mixtures were then passed through for purification. Each
conical containing the purified AMPs were spun down in a centrifuge designed for 50mL
falcon tubes and after 8 hours was completely dried. In order to quantify the
concentrations of each AMP sample, an assay (Micro BCA protein assay kit, Thermo
Scientific®) was performed using the manufacturer’s protocol. A bradykinin protein
standard was serially diluted to concentrations of 400, 200, 50, 25, 10, 5, 2.5, and 1
µg/mL were used for the standard because these are typical concentrations of AMPs
collected from L. sphenocephalus. The bovine serum albumin included in the assay kit
was not used because its peptides are significantly larger than any anuran AMPs
produced. Each AMP sample was placed into the wells at full strength and half dilution in
replicates of three. Plates were incubated at 37°C for two hours to ensure the protein
within each AMP sample was detected using the microBCA reagents. Each 96-well plate
was read twice at a wavelength of 570nm to ensure accuracy and minimize error. Gen X
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5 software was used to average each set of replicates; averages with more than 10%
variation were excluded from the analyses. Gen X 5 software data was then transferred to
be tested for statistical significance.
Statistical Analyses
All statistical analyses were performed using SPSS 21 software. Treatment and time
effects for L. sphenocephalus AMP production were tested with repeated-measures
ANOVA using 2 sample days and 5 treatment levels (N = 32). Repeated-measures
MANOVA was used to determine treatment effects over time for both viable cell counts
of probiotics and qPCR zoospore quantification (N = 22). Changes in probiotic cell
concentrations and Bd zoospore loads contained 8 sample days, 2 exposures and 5
treatment levels.
Results
Bd infection effects on bacterial colonization
The results for probiotic quantification were not as expected. Despite colonization by
probiotics J. lividum and P. fluorescens on L. sphenocephalus epidermal tissues in the
preceding experiment, individuals infected with Bd prior to bacterial exposure were not
colonized by either bacterium. When conducting viable cell counts from swabs using
standard protocol (Miles & Misra, 1938), it was determined that L. sphenocephalus was
highly resistant to colonization by J.lividum and P. fluorescens. On day 1, only four
individuals (treatments 2 and 3) in the experiment had bacterial cell counts similar to the
inoculum concentration. By day 4, viable cell counts drastically decreased and eventually
reached zero. In treatment group 4, the same trend was observed and by sample day 12,
all bacterial treatment groups were negative for viable cell counts. On average, cell
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counts on day 1 were 15-20 % lower than those from individuals colonized by probiotics
prior to Bd exposure (Chapter 2). Seven frogs had J. lividum and/or P. fluorescens on
their epidermal tissues after day 1; however, remaining frogs in bacterial treatment
groups tested negative for these bacteria (no visible colonies 24 hrs. post-incubation). As
a result of small sample sizes for those that did contain J. lividum and/or P. fluorescens
(N = 7), multiple comparisons between treatment groups were not made. However, there
were significant effects for time (repeated-measures Analysis Of Variance, ANOVA) on
bacterial concentrations, as they decreased with each day after application (F = 386.08, p
< 0.01).
AMP release during Bd infection and subsequent bacterial exposure
AMP concentrations increased significantly in response to Bd (F3,22 = 9.05 , p < 0.01)
and the addition of probiotics five days later (F3,22 = 6.609, p <0.01). No significant
differences over time were observed for the negative control (F = 1.39, p = 0.26). Using
repeated-measures MANOVA, it was determined that significant differences occurred
between bacterial treatment groups over the duration of the experiment (F3,22 = 517.77, p
<0.01). These results did not include the Bd positive control because those individuals
had all died; therefore were exempt from analysis. Significant differences for L.
sphenocephalus AMP production were found between sample days 7 and 35 (F = 12.35,
p = 0.02).
Bd zoospore loads in response to probiotic intervention
Bd-infected individuals did not have significant decreases in Bd zoospore
concentrations as a result of bioaugmentation. L. sphenocephalus individuals within J.
lividum and P. fluorescens treatment groups had Bd zoospore loads similar to one another
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(F = 1.32, p = 0.41). All but two of thirty two (6%) individuals within these groups did
not die as a result of Bd exposure by Day 35. These six frogs that survived Bd infection
did not contain any J. lividum or P. fluorescens on their epidermal tissues, suggesting that
survival was the result of innate immunity or other resident microbiota. Bd-induced
changes of the epidermal microbial composition are known to prevent the establishment
of new bacteria into the community (Jani & Briggs, 2014). Therefore, the zoospore loads
remained at levels to those without probiotics because neither J. lividum nor P.
fluorescens colonized L. sphenocephalus. Significant differences in Bd zoospore loads
were only observed between the negative control group and the bacteria treatment groups
on day 1 (F = 4.57, p = 0.04), and day 4 (F = 6.52, p = 0.03). All individuals in the Bd
positive control died within a week as a result of Bd zoospore loads exceeding 10,000
zoospore equivalents; thus, zoospore loads in these groups could not be compared to
those in probiotic treatment groups for the entire duration of this experiment.
Discussion
Discussion of findings, conclusions
This research has assessed the effects of bioaugmentation of Bd-infected L.
sphenocephalus, and confirmed, J. lividum and P. fluorescens do not serve as suitable
treatments for chytridiomycosis. L. sphenocephalus mortality rates declined as a result of
probiotic pretreatment (Chapter 2), but in this experiment, J.lividum and P. fluorescens
did not colonize the host, and therefore, did not reduce mortality of Bd-infected
individuals. There are several possible causes as to why this dichotomy occurred. First,
the microbial community structure of L. sphenocephalus could have been altered in such
a way so as to prevent new bacterial community members on the epidermis (Bletz et al.
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2013; Jani & Briggs, 2014; Woodhams et al. 2014). Second, L. sphenocephalus
epidermal tissues may have become nutritionally or spatially incompatible with the
introduced bacteria after Bd infection, lensing them ineffective (Becker et al. 2011; Jani
& Briggs, 2014; Küng et al. 2014). Third, bacterial colonies could have been removed
with sloughed skin cells resulting from Bd infection (Jani & Briggs, 2014; Woodhams et
al. 2014; Voyles et al. 2007). Based upon the results from this study, it is evident that J.
lividum and P. fluorescens are not keystone probiotic species for L. sphenocephalus; they
are ineffective Bd inhibitors at low concentrations.
Bd-induced increases in AMP production prevented L. sphenocephalus colonization
by the introduced bacteria; exponential growth of J. lividum and P. fluorescens was not
observed, and their concentrations steadily declined through day 35. Several individuals
had AMP concentrations that exceeded 200µg/mL (i.e., above the Minimum inhibitory
concentration for both bacteria), and so, this contributed to unsuccessful colonization.
The symptoms associated with chytridiomycosis mounted a strong immune response (i.e.,
high AMP concentrations) for L. sphenocephalus; however, other aspects of their innate
immunity could have contributed to the death of J. lividum and P. fluorescens.
Amphibians have many specialized cells and responses that can successfully kill
bacteria, especially when the host is faced with a potentially lethal infection (RollinsSmith, 1998; Savage & Zamudio, 2011; Voyles, Rosenblum, & Berger, 2011). Molecular
tests should address the effects of Bd-induced immune responses on newly introduced
bacteria to understand mechanisms preventing colonization.
Probiotic treatment after Bd infection in L. sphenocephalus proved less beneficial,
likely because Bd strain FMB003 was exceptionally virulent (Brem et al. 2013). More
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virulent strains of Bd are characterized by their genetics which encode for faster
infection, transmission rates, and increased mortality among susceptible populations
(Berger et al. 2005; Richmond et al. 2009). Isolate FMB003 was a fresh stock culture that
had only been transferred to culture media three times prior to inoculating L.
sphenocephalus. Individuals that survived Bd exposure, therefore, had high AMP
production that prevented probiotic colonization. In this case, J.lividum and P.fluorescens
could not have reproduced at a rate that would have exceeded that of Bd, thereby
preventing these bacteria from reducing Bd zoospore loads below the mortality threshold.
In this research study, 32 individuals were inoculated with Bd isolate FMB003 and by
day 7, more than half of L. sphenocephalus individuals died after exposure. Bd strains
can have differential effects on both amphibian populations and species (Bataille et al.
2013; Berger et al .2009). For example, Lithobates clamitans was highly susceptible to a
Panamanian Bd strain, but resistant to the North American strain (Gahl et al. 2012). It is
plausible that L. sphenocephalus in this experiment were highly susceptible to FMB003
because they could not host J. lividum and/or P. fluorescens once infected. L.
sphenocephalus that survived Bd infection (18%) were treated with anti-Bd bacteria and
yet, virtually all of them died, despite this intervention. The susceptibility of L.
sphenocephalus to Bd isolate FMB003 proves that anti-dermatophyte bacteria must be an
equally effective treatment as a preventative for chytridiomycosis. Furthermore,
amphibian probiotics should be sufficient against more than one Bd strain, particularly
because of the unpredictable susceptibility both between amphibian populations and
among individuals (Gahl et al. 2012). J. lividum and P. fluorescens are effective
inhibitors for some Bd strains and amphibian species, but in this experiment, both
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bacteria were incompetent. Bd waves can occur in naïve amphibian populations and
infections spread quickly (Lips, Diffendorfer, Mendelson III, & Sears, 2008); therefore,
the appropriate probiotics must adequately inhibit Bd, regardless of zoospore
concentrations found on the amphibian epidermis.
Understanding the epidermal community structure and AMP profile of Bd susceptible
amphibians is essential for developing feasible bioaugmentation strategies. If infected
with Bd, an amphibian may suffer a trade-off that could prevent probiotic colonization
and/or Bd inhibition (Garner et al. 2009). Bd infection could result in host dysbiosis
whereby the bacterial community no longer contributes to disease resistance or immunity.
Recommendations for future research
Previous research has used growth inhibition assays using purified AMPs and
secondary metabolites from anti-Bd bacteria to determine MICs against Bd using 96-well
microplates. This can significantly impact predictions and hypotheses that propose host
AMPs and anti-Bd bacteria will effectively inhibit Bd on the epidermis because other
compounds and microorganisms will influence these interactions. By performing
inhibition assays using a live host (as opposed to in vitro), we can assess accurate
measurements of host-pathogen dynamics and probiotic colonization. In such a case, we
can determine what host microbes remain effective Bd inhibitors after infection (Gibble,
Rollins-Smith, & Baer, 2008). Exposure history, heritability, and climate dictate bacterial
community composition and AMP profiles of amphibians; therefore, it is necessary to
make a complete analysis of their Bd inhibition efficacy before choosing an anti-Bd
probiotic.
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New technologies, such as pyrosequencing and whole-community level profiling,
have allowed for the identification of bacteria present on amphibians (Bell, 2012; Bletz et
al. 2013; Culp et al. 2007; McKenzie et al. 2011). These techniques have demonstrated
the subsequent changes of epidermal community composition after Bd infection (Jani and
Briggs, 2014). However, this data has not been used to test for compatibility between
amphibian hosts and newly introduced anti-bd bacteria. In doing so, Bd-induced
discrepancies for bacterial colonization, could be prevented. It may be possible that
because these analyses were not performed, the microbial profile on L. sphenocephalus
epidermal tissues could have changed after Bd infection. The relative abundances and
proportions of epidermal microbes could have changed in a way so as to induce
pathogenicity toward J. lividum and/or P. fluorescens (Küng et al. 2014; Loudon,
Woodhams et al. 2014). It is likely that bacterial densities of those that facilitate Bd
growth and proliferation increased, while simultaneously inhibiting Bd antagonists (Jani
& Briggs, 2014). 16-S Pyrosequencing or whole community level profiling could also
reveal more anti-Bd bacteria that have not been considered previously.
The symptoms associated with chytridiomycosis, such as skin sloughing, electrolyte
depletion and osmotic imbalance may have produced an inhospitable environment for J.
lividum and P.fluorescens. The nutritional and spatial requirements for most bacterial
species and some strains are highly specified, and even small deviations can be lethal. For
example, halotolerant organisms, such as Staphylococcus spp., are found in environments
at salt concentrations of 5-25%, and cannot survive outside of this range (Leboffe &
Pierce, 2012). Therefore, the Bd-induced changes of L. sphenocephalus epidermal tissues
were most likely outside of the specific ranges for ions, water, and other compounds that
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J. lividum and P.fluorescens require. Nonetheless, it could be that epidermal tissues
inoculated with J. lividum and/or P. fluorescens were sloughed off as the disease
progressed. Bd inhibition by probiotics can depend upon whether the amphibian(s) is
infected, and if so, the stage of disease progression at the time of probiotic application.
The amphibian immune response to pathogens may be similar to newly introduced
probiotics if the benefit is not direct or rapid. J. lividum and P. fluorescens are known Bd
inhibitors, but the imposed immune responses by L. sphenocephalus are most likely
highly regulated because of infection. Infection of L. sphenocephalus by Bd may trigger a
heightened immune response that once compromised, will not allow for any new
members of the microbial community, but rather changes in the abundances of current
microbiota. Bd mitigation efforts should focus on the alternative mechanisms of immune
responses to newly introduced anti-Bd bacteria before and after infection. This study
revealed a distinctly different immune response to probiotic exposure when L.
sphenocephalus was infected; supporting the idea that Bd influences epidermal
community composition (Harris et al. 2009; Rollins-Smith, 2013; Woodhams et al.
2014). If so, how does this change affect the immune response of Bd-infected amphibians
to other microbes that could promote longevity? This research is the next step toward
addressing how the changes imposed upon Bd-infected ranid frogs alter the process of
bacterial colonization.
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